Interdigitating Dendritic Cell Sarcoma

Also known as: Dendritic Cell Sarcoma, Interdigitating / Sarcoma of dendritic cells (accessory cells) / Interdigitating dendritic cell sarcoma (disorder) / Interdigitating dendritic cell sarcoma (morphologic abnormality)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09037Pembrolizumab2Suspended1